Although the combined activation of transforming growth factor β/WNT signaling pathways has been demonstrated to induce ZEB1-dependent repression of GRHL2 expression and EMT (23), surprisingly little is known about mechanisms and signaling pathways regulating GRHL2 activity in cancer cells. The gene discussed is GRHL2; the disease is cancer.